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Endovascular repair is not worse than open repair of abdominal
aortic aneurysms
Editor—The title and interpretation of the
EVAR trial results in the POEM are mislead-
ing and incorrect.1 Mortality figures were
quoted both as aneurysm related and all
cause deaths. The 30 day mortality was 1.7%
in the EVAR group, which is significantly
lower than 4.7% in the open repair group.
Surprisingly, the POEM somehow inter-
preted 30 day mortality to be less than 1%
for both groups, which is clearly an error.
The confidence intervals (odds ratio 0.35,
95% confidence interval 0.16 to 0.77,
P = 0.009) make type I error unlikely. If pre-
intervention deaths are added to the figures
30 day mortality was calculated at 3.5% for
endovascular repair and 7.1% for open
surgery.2
The advantage of endovascular repair is
sustained at four years, with 4% aneurysm
related deaths in the EVAR group com-
pared with 7% in the open repair group.
This confers a 3% absolute reduction in
aneurysm related mortality. The all cause
mortality rate was comparable in both
groups at four years.
Endovascular repair offers a 30 day
lower risk treatment compared with open
surgery in patients who are medically fit with
an abdominal aortic aneurysm. Compared
with open repair, endovascular repair offers
no advantage with respect to all cause mor-
tality and health related quality of life; and is
more expensive; however, it confers a 3%
improved aneurysm related survival which
persists at four years.
The POEM’s message that endovascular
repair is worse than open repair is
inaccurate and not evidence based.
Jeremy Crane specialist registrar
j.crane@imperial.ac.uk
Meryl Davies specialist registrar
Nick Cheshire professor of vascular surgery
Regional Vascular Unit, St Mary’s Hospital,
London W2 1NY
Competing interests: None declared.
1 Endovascular repair is worse than open repair of abdomi-
nal aortic aneurysms. BMJ 2005;331: 0-f. (24 September.)
2 EVAR Trial Participants. Endovascular aneurysm repair
versus open repair in patients with abdominal aortic aneu-
rysm (EVAR trial 1): randomised controlled trial. Lancet
2005;365:2179-86.
Details of HPV immunisation
need not delay decision
Editor—Lowndes and Gill are upbeat in their
appraisal of the future for primary preven-
tion of cervical cancer by immunisation.1 But
they then deliver a long list of questions that
they suggest should be answered before start-
ing human papillomavirus (HPV) vaccina-
tion. For most of their questions, this timing is
not supported by recent historical precedent.
Without doubt ascertainment of the
HPV types currently causing cancer, data for
which are available in the United Kingdom,2
is central to the modelling and cost
effectiveness studies with which we must
assume the Health Protection Agency and
others in the UK are already engaged.
Certainly, as for all recent new vaccines, cost
is likely to be a key determinant. Likewise,
careful evaluation of vaccine acceptability to
children and parents will be important,
although it should be pointed out that
universal immunisation against hepatitis B,
primarily a sexually transmitted disease and
a cancer causing virus, is already widely
established and accepted in many countries.
But the other questions need not delay
implementation and have not done so for
other immunisation programmes. The pre-
cise design and nature of any catch up
programme is a wholly separate issue from
the decision that will need to be taken as
soon as possible after one or more of these
vaccines become licensed and available in
Europe—namely, whether to offer the
vaccine to all girls before they become sexu-
ally active as a means of preventing the sec-
ond most common cancer of women. It
seems that this will be an important,
although quite possibly expensive, public
health opportunity. The case will need to be
made in a clear and uncluttered way if need-
less loss of life is to be avoided.
Adam Finn David Baum professor of paediatrics
Institute of Child Life and Health, Department of
Clinical Sciences at South Bristol, University of
Bristol, Bristol BS2 8AE
Adam.Finn@bristol.ac.uk
Competing interests: None declared.
1 Lowndes CM, Gill ON. Cervical cancer, human papilloma-
virus, and vaccination. BMJ 2005;331:915-6. (22 October.)
2 Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W et
al. Cervical HPV infection and neoplasia in a large
population-based prospective study: the Manchester
cohort. Br J Cancer 2004;91:942-53.
Omitted evidence?
Editor—I was surprised that Alvarez-
Rosete et al in their article did not discuss
what is thought to be the best piece of
evidence that the NHS in England has
improved: performance of accident and
emergency departments.1 Then I double
checked my sources.
What is clear is that English accident and
emergency departments are dramatically
better than they were five years ago, when
more than one in four people waited more
than four hours for admission or treatment.
Over the past six months fewer than two in
100 have waited more than four hours in
England. The situation in Scotland, which
boasted about being the best in the United
Kingdom in 2001,2 has certainly got worse
and is probably much worse than England.
The current Scottish figures are hard to
compare and may not be reliable as the
sampling technique (a three day sample,
once a year) may be both unrepresentative
and gameable.3 English departments have to
submit statistics on all-patient performance
weekly.
I could find no site reporting useful sta-
tistics about Wales, but according to anecdo-
tal evidence, accident and emergency per-
formance is as poor as English performance
in 2000 in some of the larger hospitals. It
seems that the experience of reform in this
part of health care in England is a success.
Debate is ongoing in these pages about
the evidence for and against reform, and it
would be ironic indeed if the evidence for
elements of reform were undermined by the
lack of information about what happens if
you don’t do it.
Stephen I Black management consultant
London SW1W 9SR
stephen.black@paconsulting.com
Competing interests: SIB has worked for the
Department of Health on accident and emer-
gency performance.
1 Alvarez-Rosete A, Bevan G, Mays N, Dixon J. Effect of
diverging policy across the NHS. BMJ 2005;331:946-50.
(22 October.)
2 Scottish Excecutive News. Scottish A&E departments lead UK
www.scotland.gov.uk/News/Releases/2001/11/694
(accessed 28 Oct 2005).
3 Scottish Health Statistics. Accident and emergency waiting
times. www.isdscotland.org/isd/info3.jsp?pContentID =
3589&p_applic = CCC&p_service = Content.show&
(accessed 28 Oct 2005).
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Informed consent
Talking with patients, not at them
Editor—“Informed consent”1 seems to be a
term that sends doctors and lawyers off into
preconditioned behaviours rather than
thinking about what we are really trying to
achieve—probably normal behaviour for
lawyers from my experience.
What we are trying to do is to help a
patient make an informed choice about pro-
ceeding with the suggested
treatment. Doctors are so
focused on “treating” patients,
and solving the problem, that
they seem to forget that the
patient is involved too.
“Consenting” is not
something that should be
done to a patient—it is some-
thing patients do when they
have the information they
need. For surgery or other
invasive treatments, the doc-
tor needs a consent form for
their protection—but that
should be after the patient
has chosen—recording the fact of consent.
Too often the signing of the form is viewed
as the “consent”—it can still be challenged in
law.
Patients need to know that there are
risks and that doctors are human and make
mistakes. They do not necessarily need the
graphic detail, but it should be there if they
either ask or appear interested.
What patients need is an effective
dialogue with the doctor and the healthcare
system. Leaflets may help, but listening and
talking on a personal level is much more
effective, but requires doctors to allow
patients to direct the process.
It can go to the other extreme—last month
in the accident and emergency department I
had to help the doctor complete my consent
form. Occasionally the patient may be better
informed than the clinician.
Peter D Singleton senior associate
Judge Business School, University of Cambridge,
Cambridge CB2 1AG
peter.singleton@chi-group.com
Competing interests: PDS was an author of the
report The Informed Patient, produced by
Cambridge University Health.
1 Rowbotham D. Informed consent (and a flutter in Vegas).
BMJ 2005;331:973. (22 October.)
Is frightening patients really in their best
interests?
Editor—Rowbotham raises some issues in
his article that are familiar to us as surgical
trainees.1 We are often in the position of
obtaining patients’ consent for operations
which, although clearly in their best inter-
ests, entail the discussion of rarely occurring,
but serious, risks, leaving the patient worried
about rare, but serious, complications.
Unfortunately, in today’s climate of ever
increasing litigious activity it becomes ever
more important to ensure all possible com-
plications are mentioned, since failure to do
so could risk serious problems for the
doctors involved. Many patients in our expe-
rience are keen to proceed with the
procedure, and being informed of such
complications does nothing but contribute
to the stress already felt by many in prepar-
ing themselves for an operation. At a time
when many are seeking reassurance, are we
really acting in the patients’ best interests?
We note the comments and suggestions
of Professor John Harris mentioned in the
bmj.com news roundup by Davies with regard
to offering patients the choice of
a simple consent as an alterna-
tive option.2 This would allow
doctors to act in accordance
with the patient’s wishes, yet
protect against litigation. We
agree that this could offer a use-
ful alternative. Of course, the
option of fully informing
patients of all possible compli-
cations would and should
remain. In a society in which
patients’ choice is a sought after
gold standard, surely it seems
logical to take account of the
variety of different patients’
views in the amount of information they seek
and the degree of professional guidance they
wish to allow. It would be refreshing to see a
system in place that allowed patients’ consent
to be guided by patients’ choice rather than
the ugly fear of litigation.
Christopher P J Wood senior house officer, orthopaedic
surgery
cpjwood@hotmail.com
Simon C Blackburn senior house officer, orthopaedic
surgery
Brighton and Sussex University Hospitals NHS Trust,
Royal Sussex County Hospital, Brighton BN2 5BE
Competing interests: None declared.
1 Rowbotham D. Informed consent (and a flutter in Vegas).
BMJ 2005;331:973. (22 October.)
2 Davies J. Doctors should be allowed to offer patients a sim-
plified form of consent, expert says. BMJ 2005;331:925 (22
October).
Danger is ahead when staff don’t know
what they don’t know
Editor—The perception that many health-
care professionals fail to understand fully
the law on consent seems to have been con-
firmed in some of the responses to
Rowbotham’s article.1 An enduring right
already exists for practitioners to omit
information in relation to risks that they
consider not in their client’s best interests to
hear. Practitioners have no need to repeat a
long list of every potential adverse risk of
treatment, unless explicitly requested to by
the client: whether this is a paternalistic rem-
nant fit to be consigned to a bygone age or
not depends on the individual viewpoint. The
other extreme of simply handing out leaflets
is equally concerning and would most
certainly expose any practitioner to claims of
poor practice in the realm of consent.
Junior medical staff and other health-
care practitioners require support and guid-
ance to ensure that they are not being
railroaded into routinely frightening clients,
in the pursuit of a signature on a potentially
useless piece of paper. The basic tenets of
consent instruct us that clients must be
informed, in possession of all their faculties,
and acting voluntarily. By scaring them
witless they are highly unlikely to meet any
one of these three criteria.
The propagation of the spectre of litiga-
tion seems to be fostered as much by the
medical fraternity itself as the media. Litiga-
tion in the realm of injuries arising from a
defective consent process is comparatively
rare—complaints, an apology, and a willing-
ness to change for the better are the more
usual requirements. And on the occasions
where it does arise, why shouldn’t someone
gain a pecuniary advantage when their
health is irreversibly affected? Wouldn’t you
expect it for yourself?
Notwithstanding, I agree that there is no
need for complacency, but it is high time
that the aforementioned support and
guidance is provided for individual practi-
tioners to ensure that only partly informed,
and sometimes unwisely held beliefs are
eradicated.
Donna O’Boyle director
c3healthsolutions, Edinburgh EH12 9HJ
donna@c3healthsolutions.co.uk
Competing interests: None declared.
1 Rowbotham D. Informed consent (and a flutter in Vegas).
BMJ 2005;331:973. (22 October.)
Are consenters representative
of a target population?
Editor—I write with reference to the paper
by Junghans et al on recruiting patients to
medical research.1 We recently published a
method to determine if consenters to popu-
lation surveys are representative of the
target study population.2
Recently introduced data protection leg-
islation has changed research practice in the
United Kingdom, although uncertainties
about the interpretation of the legislation
remain.3 Methods such as searching general
practice records to investigate whether non-
responders are different to responders are
no longer acceptable as they use informa-
tion about identifiable individuals without
their consent. An alternative approach to
estimating the effect of non-response is to
reformulate the problem as the extent to
which responders are representative of the
total target population. Since anonymised
data may be obtained and used for the target
population as a whole, this represents an
indirect way of assessing the impact of non-
response on representativeness. We com-
pared consultation rates for some common
conditions among responders to a headache
survey4 who had consented to the use of
their practice records for research with ano-
nymised rates derived from the practice
populations from which they were sampled.
We found that the adjusted consultation
rates were similar but generally higher in the
consenters group than in the population
group. This shows that consenters have
more morbidity than those who do not par-
ticipate, not only with respect to the topic of
R
O
N
SU
TH
ER
LA
ND
/S
PL
Letters
1082 BMJ VOLUME 331 5 NOVEMBER 2005 bmj.com
the survey (headache) but for other condi-
tions also. However, the differences were not
large and imply that non-response bias is
unlikely to be substantial with respect to the
extent and pattern of ill health.
The alternative method that we
described offers one potential approach to
determine whether respondents to a study
are representative of the population from
which they were sampled with respect to a
particular set of characteristics—namely,
their morbidity as measured by consultation
with a general practitioner—and as such can
be used as one measure of the representa-
tiveness of the responding sample.
David S Millson general practitioner principal
Leek Health Centre, Fountain Street, Leek
ST13 6JB
david.millson@tiscali.co.uk
Competing interests: None declared.
1 Junghans C, Feder G, Hemingway H, Timmis A, Jones M.
Recruiting patients to medical research: double blind ran-
domised trial of “opt-in” versus “opt-out” strategies. BMJ
2005;331:940. (22 October.)
2 Boardman HF, Thomas E, Ogden H, Croft PR,Millson DS.
A method to determine if consenters to population
surveys are representative of the target study population. J
Public Health Med 2005;27:212-4.
3 Strobl J, Cave E, Walley T. Data protection legislation:
interpretation and barriers to research. BMJ 2000;321:
890-2.
4 Boardman HF, Thomas E, Croft PR, Millson DS. Epidemi-
ology of headache in an English district. Cephalalgia
2003;23:129-137.
Mandatory reporting of all
sexually active under-13s
Confidential sexual health services to
young people: part of the solution or part
of the problem?
Editor—Bastable and Sheather offer little
evidence as to what would happen if limits
were placed on confidential underage access
to sexual health services.1 They mention the
United States without mentioning the
relevant empirical data there, as for example
summarised by the economist Levine in a
recent analysis of US and international data
on abortion.2 Levine finds that parental
involvement laws actually reduce abortion
rates of minors by 10-20%. More impor-
tantly, there is no evidence of a concomitant
increase in the rate of underage births.
Teenage pregnancies either remained
unchanged or even fell.
Levine et al find that US states
restricting Medicaid funding for abortion
during 1977-88 led to a decrease in their
pregnancy rates of 7.7%.3 This too implies
that increasing access to abortion increases
the incidence of unprotected sex.
Another “social experiment” that contra-
dicts the assumptions by Bastable and
Sheather occurred at the time of the Gillick
ruling,4 which restricted access for under 16
year olds to family planning in England and
Wales, but not in Scotland. If Bastable and
Sheather were correct, the 1984 ruling
should have been associated with an increase
in underage pregnancies at the time.
However, the opposite occurred: no increase
in England and Wales, but an increase in the
underage pregnancy rate in Scotland.5
The explanation for these findings lies in
the economic (and not just medical) model
of teenage sexual activity including teenage
pregnancy: easy and confidential access to
family planning services (including abor-
tion) acts essentially as an “insurance”
against the unwanted risks of sexual activity.2
It therefore leads to an overall increase in
sexual activity, as the “risk” of sexual activity
(unwanted pregnancy especially) has been
reduced.
Despite free and confidential access to
family planning clinics, teenage pregnancies
have therefore not fallen and sexually trans-
mitted infections have risen substantially
over the past decades. Is confidentiality—at
least partly—to blame?
Hans-Christian Raabe fellow, environmental health
clinic
Toronto, ON, Canada M5S 1B2
hcraabe@yahoo.com
Competing interests: None declared.
1 Bastable R, Sheather J. Mandatory reporting to the police
of all sexually active under-13s. BMJ 2005;331:918-9. (22
October.)
2 Levine P. Sex and consequences. Abortion, public policy and the
economics of fertility. Princeton: Princeton University Press,
2004.
3 Levine PB, Trainor AB, Zimmerman DJ. The effect of
Medicaid abortion funding restrictions on abortions, preg-
nancies, and births. J Health Econ 1996;15:555-78.
4 Gillick v West Norfolk andWisbech Area Health Authority
and the DHSS (1984) Queen’s Bench Reports (England)
581.
5 Paton D. The economics of family planning and underage
conceptions. J Health Econ 2002;21:27-45.
Reporting is a public health imperative
Editor—We write with reference to the edi-
torial by Bastable and Sheather.1 The
consultation document from the Depart-
ment for Education and Skills outlines the
principles of sharing information about
sexually active youngsters among the agen-
cies that deal with them. Although the inten-
tions of this proposed legislation are good,
the intricacies of its application make it
impractical. Some of these problems are well
highlighted in the editorial. However, more
importantly, it can have adverse implications
for certain public health issues.
With the growing incidence of teenage
pregnancy (that includes under-13s) and
abortion rates in the United Kingdom,2
sexually active teenagers should be encour-
aged by all means to attend counselling
sessions and to seek medical help in times of
need. Any threat to their confidentiality will
certainly deter them from seeking help. In
addition, delays in presentation for abortion
preclude them from accessing safer medical
methods. Subsequent surgical methods of
termination are associated with more com-
plications. More importance has to be given
to maintaining the health of the teenagers.
Another major public health threat is
the possible increase in the incidence of
sexually transmitted infections and associ-
ated problems. Disclosure of information to
parents and other professionals could
potentially drive teenagers away from
seeking medical help, promoting further
transmission.3
Although, such legislation is existent in
countries such as the United States, the inci-
dence of births to 15-19 year olds in
America is still higher than that in the UK
(61/1000 compared with 33/1000).4
Good communication, a good relation-
ship with a doctor or nurse, and non-
judgmental attitudes in all staff can help
encourage young people to use services.5 We
think that the legislation is being brought as
a knee jerk reaction to the report on the
Soham murders case, without considering
all determinants of health.
Somasundari Gopalakrishnan honorary observership
somla@tiscali.co.uk
R Nicholas Pugh consultant public health
Walsall Teaching Primary Care Trust, Walsall, West
Midlands WS1 1TE
Competing interests: None declared.
1 Bastable R, Sheather J. Mandatory reporting to the police
of all sexually active under-13s. BMJ 2005;331:918-9. (22
October.)
2 Barrett A. Abortions reach highest ever number in
England and Wales. BMJ 2005;331:310. (6 August.)
3 Brown AE, Sadler KE. Recent trends in HIV and other STIs
in UK:data to end of 2002.Sex Transm Infect 2004;80:159-66.
4 Free C, Lee R, Ogden J. Young women’s accounts of the
factors influencing their use and non-use of emergency
contraception: in-depth interview study. BMJ 2002;325:
1393-6.
5 Tanne JH. Teenagers need sex education, not just
abstinence advice. BMJ 2005;331:129.
Author rectifies omission:
health behaviour change in the
developing world
Editor—I want to acknowledge an omission
in the paper I wrote on behaviour change
with colleagues with expertise in communi-
cations.1 Our first sentence places the
context for the paper in the developed
world, as if the far more widespread poor
health and associated behaviour problems
in the developing world are of less
importance. The effects of poor housing,
social upheaval, and other forms of depriva-
tion manifest themselves widely in the
consulting rooms of practitioners in the
developing world, placing a huge burden on
them to help patients as best they can.
Having made this mistake, there is not
much else that needs be said about the
potential of a guiding style in behaviour
change consultations in developing coun-
tries. It is clearly relevant and, I believe,
adaptable across cultures. In fact, given my
impression of quite widespread morale
problems among overburdened practition-
ers in the developing world, skilfulness in
using a guiding style can help them to feel
less responsible for solving health behaviour
problems they encounter every day. As for
the listening component, I am yet to come
across a practitioner from a culture or
language group who does not affirm the
value of listening to patients.
Stephen Rollnick professor of healthcare
communication
Department of General Practice, Centre for Health
Sciences Research, Cardiff University, Cardiff
CF14 4XN
rollnick@cf.ac.uk
Competing interests: None declared.
1 Rollnick S, Butler CC,McCambridge J, Kinnersley P, Elwyn
G, Resnicow K. Consultations about changing behaviour.
BMJ 2005;331:961-3. (22 October.)
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Are medical schools fit for
graduates?
Editor—James may be ready for a UK wide
system of graduate entry medical educa-
tion,1 but are we sure that UK medical
education is ready for graduates? Absurdi-
ties remain at all stages of the current train-
ing system—the Joint Committee on Higher
Medical Training states that a three year
doctorate completed before or during medi-
cal school will count less towards specialty
training than, for example, a weekend of
research as a senior house officer.2
What signal does this send to those
engaged in BM-PhD programmes? Graduate
entrants to medicine have been reported to
findmedical school more stressful than school
leavers.3 Perhaps the suggested national quan-
titative assessment of knowledge (analogous to
the US medical licensing exams, USMLE)
would allow selection and then fast tracking
of motivated students through foundation
competences while still in medical school,
thus avoiding the stress associated with
feelings of stagnation felt by some graduates
while completing a training programme
designed, and paced, for school leavers.4
Might the current “fluid” state of
Modernising Medical Careers allow the
incorporation of foundation years into a five
year integrated graduate entry medicine
training programme? Will revised “run
through” programmes for specialty training
accommodate and acknowledge any post-
graduate research training (especially that
funded by research councils and resulting in
graduate degrees) without reference to the
date of medical qualification? Might such
joined-up thinking even encourage more
scientists into clinical training and help
tackle the shortage of clinical academics?
I await the answers with interest but in
the meanwhile I’m not going to stop
studying for the USMLEs just yet.
Christopher S Hourigan medical student
Worcester College, Oxford OX1 2HB
chris@hourigans.org
Competing interests: CSH is a graduate entry
medical student.
1 James WS. Students need education fit for professional
and public life. BMJ 2005;331:966. (22 October.)
2 Joint Committee on Higher Medical Training. Frequently
asked questions. General queries/UK trainees. Point 14.
www.jchmt.org.uk/faq.asp (accessed 25 Oct 2005).
3 Rolfe IE, Ringland C, Pearson SA. Graduate entry to medi-
cal school? Testing some assumptions. Med Educ 2004;
38:778-86.
4 Wass V. Ensuring medical students are “fit for purpose.”
BMJ 2005;331:791-2. (8 October.)
Psychological impact of alopecia
Alopecia may lead to social anxiety
Editor—Hunt and McHale conducted an
extensive clinical review about the psycho-
logical impact of alopecia.1 Alopecia is
psychologically damaging, causes intense
emotional suffering, and leads to personal,
social, and work related problems.1 2
Although stressful life events may have an
important role in triggering some episodes of
alopecia,1 the anxiety symptoms that follow its
appearance may closely resemble social anxi-
ety disorder. Some patients with alopecia
have anxiety symptoms, avoidance behaviour,
and social and economic suffering similar to
social anxiety disorder patients. Social anxiety
disorder is characterised by the fear of
humiliation or being judged negatively in
social situations as well as the avoidance of
such social or performance situations.3 The
diagnosis of social anxiety disorder excludes
patients whose social fears and avoidance are
secondary to other psychiatric disorders or
medical problems (for example, essential
tremor or stuttering).
Patients with alopecia initially unrelated
to social anxiety may begin to avoid public
situations out of fear that it would be embar-
rassing if others observed the loss of hair,
and they may experience excessive fear of
being humiliated or of embarrassment when
their alopecia is noticed. Identical to patients
with primary social anxiety, they tend to be
self conscious and self critical, and they often
experience physical symptoms of anxiety,
such as blushing, palpitations, sweating, and
trembling. Such secondary social anxiety
disorder has the same symptoms, behaviour,
and consequences of the primary subtype.4
Patients with social anxiety disorder second-
ary to disfiguring or disabling medical
conditions experience serious social anxiety
and avoidance, and since such symptoms
have been shown to respond to antidepres-
sant drugs,5 controlled trials should be
conducted to describe the response of
secondary social anxiety and avoidance to
pharmacological treatment.
Antonio E Nardi associate professor of psychiatry
Federal University Rio de Janeiro, R Visconde de
Piraja, 407/702, Rio de Janeiro, 22410-003, Brazil
antonionardi@terra.com.br
Competing interests: None declared.
1 Hunt N, McHale S. The psychological impact of alopecia.
BMJ 2005;331:951-3. (22 October.)
2 Hunt N, McHale S. Reported experiences of persons with
alopecia areata. J Loss Trauma 2005;10:33-50.
3 Schneier F. Social anxiety disorder. BMJ 2003;327:515-6.
4 Nardi AE. Social anxiety disorder has social and economic
burden. BMJ 2003;327:1287.
5 Nardi AE. Antidepressants in social anxiety disorder. Arq
Neuropsiquiatr 2001;59:637-42.
Don’t forget syphilis
Editor—I write with reference to the article
by Hunt and McHale.1 Late syphilis can be a
cause of atypical alopecia. Some 30 years ago
the BMJ ran an article about alopecia and
syphilis.2 Within a month, I saw a patient who
had apparently been complaining of patchy
“alopecia areata” for some time. The appear-
ances and long history did not seem to fit any
alopecia areata that I had seen. The “very long
shot” serology result confirmed a specific cau-
sation, which turned out to be the uncon-
fessed late result of an affair years previously.
It was interesting that the specific treatment
also cured another problem of “detergent
hand dermatitis” as well as the alopecia.
Martin F Brewster retired general practitioner
Wigtown, Scotland DG8 9DZ
forrie@globalnet.co.uk
Competing interests: None declared.
1 Hunt N, McHale S. The psychological impact of alopecia.
BMJ 2005;331:951-3. (22 October.)
2 Kennedy C. Syphilis presenting as hair loss. BMJ 1976;ii:
854.
Speaking from personal experience
Editor—I had to respond to the article on
alopecia by Hunt and McHale,1 if only to
show how attitudes have changed in the past
four decades. I lost every hair on my head in
1965, when I was 17 and doing my A levels.
I had two wigs, both made out of Chinese
hair, which had to be cleaned from time to
time. One looked a lot more like my own
hair than the other.
I played a lot of hockey and netball at
school so I had to wear a headband to keep
the wig in place. One day, at netball practice
it fell off. As far as I can remember I picked
it up and put it on again—and no one said a
word—I suppose they were embarrassed. I
had a polystyrene head on which I used to
put the wig at night.
I had ultraviolet therapy to make my
hair grow back a bit quicker—so I had nice
tan that year. By the time I went to university
in the autumn I had a sort of fine down cov-
ering my head, which very soon looked as
though I had spent a fortune getting some
highlights done.
I survived the experience—and I am not
sure if I am psychologically scarred or not. I
still have the odd bald patch now and
again—which just jogs my memory a little bit.
Diana M Amor scientific editor
Reading Scientific Services Limited, Reading
RG6 6LA
diana.m.amor@rssl.com
Competing interests: None declared.
1 Hunt N, McHale S. The psychological impact of alopecia.
BMJ 2005;331:951-3. (22 October.)
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